What is seborrheic dermatitis, its causes, symptoms, and treatment options, particularly in adults with oily skin or a history of psoriasis, eczema, or rosacea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seborrheic Dermatitis: Clinical Description

Seborrheic dermatitis is a chronic inflammatory skin condition affecting sebaceous-rich areas (scalp, face, chest) that presents with greasy yellowish scaling, erythema, and itching, caused by an inflammatory response to Malassezia yeast. 1

Clinical Presentation

Characteristic Features:

  • Greasy yellowish scaling with erythematous patches on sebaceous-rich skin areas 1
  • Primary locations: scalp, central face, ears, chest, back, axilla, and groin 2, 3
  • Associated pruritus (itching) with secondary inflammation from Malassezia yeast 1
  • Poorly defined erythematous patches with scaling 4

Distribution Pattern:

  • In adults: scalp involvement ranges from mild patches to diffuse scaling 3
  • Facial involvement: central face, eyebrows, nasolabial folds 2
  • In infants: yellowish scaly patches on scalp ("cradle cap") 3

Pathophysiology and Causative Factors

Primary Mechanism:

  • Malassezia species metabolize sebum triglycerides into irritating free fatty acids that trigger localized inflammation 5, 6
  • Occurs specifically in areas with high sebaceous gland density 1
  • Involves decreased fungal diversity with increased Malassezia colonization 6

Contributing Factors:

  • Sebaceous gland activity and sebum production 3, 7
  • Immune dysfunction and inflammatory response 3, 7
  • Skin barrier dysfunction 7

Associated Conditions and Risk Factors

High-Risk Populations:

  • More pronounced in: HIV infection, Parkinson's disease, and Down syndrome 1, 5, 6
  • Frequently coexists with rosacea (51% of cases) 1, 6
  • Associated with dry eye conditions (25-40% of cases) 1, 5, 6

Systemic Nature:

  • 95% of patients with seborrheic blepharitis have seborrheic dermatitis elsewhere on the body 1, 5, 6
  • Often coexists with other dermatologic conditions including eczema and psoriasis 1

Differential Diagnosis Considerations

Must Distinguish From:

  • Atopic dermatitis: chronic pruritus starting in childhood, multiple body areas involved, different scaling pattern 1
  • Psoriasis: characteristic silvery scale, indurated plaques, different distribution 1
  • Contact dermatitis: history of allergen exposure, different clinical pattern 1
  • In infants: difficult to separate from seborrheic dermatitis initially 1

Key Distinguishing Features:

  • Seborrheic dermatitis: greasy yellowish scaling, affects sebaceous areas, spares groin/axilla 1
  • Atopic dermatitis: xerotic scaling, lichenification, typically spares sebaceous areas 1

Treatment Approach

First-Line Therapy:

  • Topical antifungals targeting Malassezia: ketoconazole, ciclopirox, miconazole 6, 8, 3, 7
  • Ketoconazole 2% cream applied twice daily for four weeks or until clinical clearing 8

Adjunctive Anti-Inflammatory Treatment:

  • Low-potency topical corticosteroids for short-term use to control inflammation and itching 5, 6, 9, 3
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) for facial involvement 1, 3, 7

Maintenance Therapy:

  • Ongoing antifungal therapy required due to chronic relapsing nature 5, 6, 7
  • Coal tar preparations for scalp involvement 10, 2
  • Keratolytic agents (salicylic acid) and humectants (propylene glycol) 3

Severe or Resistant Cases:

  • Systemic antifungals (terbinafine, itraconazole) reserved for widespread or refractory disease 2, 3
  • UVB phototherapy may be considered 3

Clinical Pitfalls

Common Mistakes to Avoid:

  • Failing to recognize the systemic nature—check for involvement at multiple sebaceous sites 5, 6
  • Overlooking associated conditions (rosacea, dry eye) that require concurrent management 1, 6
  • Using high-potency corticosteroids or prolonged steroid therapy—stick to low-potency short-term use 5, 6, 3
  • Discontinuing treatment after initial clearing—maintenance antifungal therapy prevents relapse 5, 6, 7
  • In immunocompromised patients (HIV, Parkinson's), expect more severe presentation requiring aggressive treatment 1, 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of seborrheic dermatitis: a comprehensive review.

The Journal of dermatological treatment, 2019

Research

An Overview of the Diagnosis and Management of Seborrheic Dermatitis.

Clinical, cosmetic and investigational dermatology, 2022

Research

Seborrheic dermatitis: an update.

Acta dermatovenerologica Croatica : ADC, 2012

Guideline

Fungal Association in Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Seborrheic Dermatitis Pathophysiology and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Understanding of Seborrheic Dermatitis: Treatment Options.

Journal of cutaneous medicine and surgery, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.